Pneumonitis in Patients Treated With Anti-Programmed Death-1/Programmed Death Ligand 1 Therapy (vol 35, pg 709, 2017)

被引：2
|
作者：
Naidoo
Long, Georgina
Hellmann, Matthew
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷 / 22期
关键词：
D O I：
10.1200/JCO.2017.74.5042
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2590 / 2590
页数：1
相关论文
共 50 条
  • [1] Pneumonitis in Patients Treated With Anti-Programmed Death-1/Programmed Death Ligand 1 Therapy
    Naidoo, Jarushka
    Wang, Xuan
    Woo, Kaitlin M.
    Iyriboz, Tunc
    Halpenny, Darragh
    Cunningham, Jane
    Chaft, Jamie E.
    Segal, Neil H.
    Callahan, Margaret K.
    Lesokhin, Alexander M.
    Rosenberg, Jonathan
    Voss, Martin H.
    Rudin, Charles M.
    Rizvi, Hira
    Hou, Xue
    Rodriguez, Katherine
    Albano, Melanie
    Gordon, Ruth-Ann
    Leduc, Charles
    Rekhtman, Natasha
    Harris, Bianca
    Menzies, Alexander M.
    Guminski, Alexander D.
    Carlino, Matteo S.
    Kong, Benjamin Y.
    Wolchok, Jedd D.
    Postow, Michael A.
    Long, Georgina V.
    Hellmann, Matthew D.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (07) : 709 - +
  • [2] Pulmonary Infiltrates in Patients Treated with Anti-Programmed Death-1/Programmed Death Ligand 1 Therapy
    Okada, A.
    Ota, K.
    Horimoto, K.
    Ibaraki, T.
    Murakami, S.
    Takenaka, H.
    Choh, S.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S1079 - S1080
  • [3] Myocarditis in patients treated with anti-programmed death-1/programmed death ligand 1 therapy.
    Wang, Hanping
    Guo, Xiaoxiao
    Tian, Ran
    Si, Xiaoyan
    Zhang, Xiaotong
    Wang, Jiangshan
    Zhao, Haitao
    Zhang, Li
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [4] Anti-programmed death-1 and anti-programmed death-ligand 1 antibodies in cancer therapy
    Hamid, Omid
    Carvajal, Richard D.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2013, 13 (06) : 847 - 861
  • [5] Risk factors for and characteristics of pneumonitis in patients treated with anti-programmed death-1 therapy.
    Hu, Yi
    Cui, Pengfei
    Zhang, Jing
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (05)
  • [6] Surrogate endpoints for overall survival in anti-programmed death-1 and anti-programmed death ligand 1 trials of advanced melanoma
    Nie, Run-Cong
    Yuan, Shu-Qiang
    Wang, Yun
    Zou, Xue-Bin
    Chen, Shi
    Li, Shu-Man
    Duan, Jin-Ling
    Zhou, Jie
    Chen, Guo-Ming
    Luo, Tian-Qi
    Zhou, Zhi-Wei
    Li, Yuan-Fang
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2020, 12
  • [7] Risk factors for pneumonitis in patients treated with anti-programmed death-1 therapy: A case-control study
    Cui, Pengfei
    Liu, Zhefeng
    Wang, Guoqiang
    Ma, Junxun
    Qian, Yuanyu
    Zhang, Fan
    Han, Chun
    Long, Yaping
    Li, Ye
    Zheng, Xuan
    Sun, Danyang
    Zhang, Jing
    Cai, Shangli
    Jiao, Shunchang
    Hu, Yi
    CANCER MEDICINE, 2018, 7 (08): : 4115 - 4120
  • [8] Outcomes of long-term responders to anti-programmed death 1 and anti-programmed death ligand 1 when being rechallenged with the same anti-programmed death 1 and anti-programmed death ligand 1 at progression
    Bernard-Tessier, A.
    Baldini, C.
    Martin, Patricia
    Champiat, Stephane
    Hollebecque, Antoine
    Postel-Vinay, Sophie
    Varga, Andrea
    Bahleda, Rastilav
    Gazzah, Anas
    Michot, Jean-Marie
    Ribrag, Vincent
    Armand, Jean-Pierre
    Marabelle, Aurelien
    Soria, Jean-Charles
    Massard, C.
    EUROPEAN JOURNAL OF CANCER, 2018, 101 : 160 - 164
  • [9] Surrogate endpoints for overall survival in anti-programmed death-1 and anti-programmed death ligand 1 trials of advanced melanoma.
    Nie, Run-Cong
    Yuan, Shu-Qiang
    Li, Yuanfang
    Chen, Yingbo
    Zhou, Zhiwei
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [10] Adrenal Insufficiency Related to Anti-Programmed Death-1 Therapy
    Ariyasu, Ryo
    Horiike, Atsushi
    Yoshizawa, Takahiro
    Dotsu, Yosuke
    Koyama, Junji
    Saiki, Masafumi
    Sonoda, Tomoaki
    Nishikawa, Shingo
    Kitazono, Satoru
    Yanagitani, Noriko
    Nishio, Makoto
    ANTICANCER RESEARCH, 2017, 37 (08) : 4229 - 4232
12345